The inotropic vasodilator, ICI 153,110, a phosphodiesterase inhibitor intended for the treatment of congestive heart failure, was administered to Alderley Park Wistar-derived rats for periods of up to 182 days. Treatment produced hypertrophy of salivary glands, hyperplasia of intestinal mucosa, and dacryoadenitis of the harderian gland. As the functions of these glandular tissues can be modified by factors which alter cyclic nucleotide metabolism, it is postulated that the glandular alterations produced by ICI 153,110 occurred as a result of phosphodiesterase inhibition.
1. Barka T and Van der Noen H (1976). Stimulated growth of submandibular gland. Lab. Invest.35: 507.
2.
2. Brenner GM and Stanton HC (1970). Adrenergic mechanisms responsible for submandibular salivary glandular hypertrophy in the rat. J. Pharmacol. Exp. Ther.173: 166.
3.
3. Bylund DB, Forte LR, Morgan DW, and Martinez JR (1981). Effects of chronic reserpine administration on beta adrenergic receptors, adenyl cyclase and phosphodiesterase of the rat submandibular gland. J. Pharmacol. Exp. Ther.218: 134.
4.
4. Fabry P and Kujalova V (1960). Enhanced growth of the small intestine in rats as a result of adaptation to intermittent starvation. Acta Anat. (Basel)43: 264.
5.
5. Forrester JM (1972). The number of villi in rat's jejunum and ileum: effect of normal growth, partial enterectomy and tube feeding. J. Anat.111: 283.
6.
6. Hargreaves RB: E.P. 0081906, 4 November 1982.
7.
7. Humphreys-Beher MG (1985). Strain-specific differences in the proline-rich proteins and glycoproteins induced in rat salivary glands by chronic isoprenaline treatment. Biochem. J.230: 369.
8.
8. Jacobs LR (1983). Effects of dietary fibre on mucosal growth and cell proliferation in the small intestine of the rat: A comparison of oat bran, pectin and guar with total fibre deprivation. Am. J. Clin. Nutr.6: 954.
9.
9. Jacobs LR, Bloom S, and Harsoulis P (1975). Intestinal adaptation in hypothermic hyperphagia. Clin. Sci. Mol. Med.48: 14.
10.
10. Kennedy MFG, Tutton PJM, and Barkla DH (1983). Adrenergic factors involved in the control of crypt cell proliferation in jejunum and descending colon of mouse. Clin. Exp. Pharmacol. Physiol.101: 577.
11.
11. Lachance MP (1982). The pharmacology and toxicology of caffeine. J. Food Safety4: 71.
12.
12. Novi AM and Baserga R (1971). Association of hypertrophy and DNA synthesis in mouse salivary glands after chronic administration of isoproterenol. Am. J. Pathol.62: 295.
13.
13. Sakai T (1981). The mammalian harderian gland: Morphology, biochemistry, function and phylogeny. Arch. Histol. Jap.44: 299.
14.
14. Selye H, Veilleux R, and Cantin M (1961). Excessive stimulation of salivary gland growth by isoproterenol. Science133: 44.
15.
15. Schneyer CA and Cheung H (1987). Ca-ATPase activity in salivary glands of rats treated with reserpine, isoproterenol, terbutaline or dobutamine. Archs Oral Biol.32: 445.
16.
16. Smith GS, Barsoum NJ, DiFonzo CJ, McEwen BJ, Macallum GE, and Greaves P (1988). Effects of cardiotonic phosphodiesterase inhibitors on rat salivary gland. 39th ACVP Meeting Abstracts, Kansas City.
17.
17. Tutton PJM and Helme RD (1974). The influence of adrenoreceptor activity on crypt cell proliferation in the rat jejunum. Cell Tissue Kinet.7: 125.
18.
18. Wells DG and Humphreys-Beher MG (1985). Analysis of protein synthesis in rat salivary glands after chronic treatment with beta receptor agonists and phosphodiesterase inhibitors.Biochem. Pharmacol.34: 4229.
19.
19. Westwood FR, Iswaran TJ, and Greaves P (1990). Pathologic changes in blood vessels following administration of an inotropic vasodilator (ICI 153,110) to the rat. Fundam. Appl. Toxicol.14: 797.
20.
20. Williamson RCN, and Chir M (1978). Intestinal adaptation. N. Engl. J. Med.298: 1393.
